Search results for "Status"

showing 10 items of 2571 documents

Pancreatic insufficiency in celiac disease is not dependent on nutritional status

1994

To determine the relationship between pancreatic secretory capacity and nutritional status in celiac patients, we studied 52 patients with celiac disease (24 males, 28 females; age range 6-36 months) and 30 healthy control subjects (14 males, 16 females; age range 6-42 months). A secretin-cerulein test was performed on all patients, and levels of serum albumin and plasma fibronectin were assayed. In addition, weight/height ratios were calculated in the celiacs, who were then divided into three groups on this basis, as follows: celiacs with weight/height ratioor = 3rd percentile; those with weight/height ratio between the 4th and 10th percentiles; and those with weight/height ratio10th perce…

Malemedicine.medical_specialtyPercentilePhysiologyBiopsySerum albuminNutritional StatusDiseaseStatistics NonparametricPathogenesisSecretinInternal medicineIntestine SmallmedicineHumansProspective StudiesLipaseChi-Square DistributionbiologyChemistryGastroenterologyAlbuminInfantNutritional statusHepatologyCeliac DiseasePancreatic Function TestsEndocrinologyChild Preschoolbiology.proteinExocrine Pancreatic InsufficiencyFemaleCeruletideDigestive Diseases and Sciences
researchProduct

The role of fear-avoidance cognitions and behaviors in patients with chronic tinnitus.

2012

The current study investigated the role of fear-avoidance-a concept from chronic pain research-in chronic tinnitus. A self-report measure the "Tinnitus Fear-Avoidance Cognitions and Behaviors Scale (T-FAS)" was developed and validated. Furthermore, the role of fear-avoidance behavior as mediator of the relationship between anxiety sensitivity and tinnitus handicap was investigated. From a clinical setting, N = 373 patients with chronic tinnitus completed questionnaires assessing tinnitus handicap (Tinnitus Handicap Inventory), anxiety, depression (Hospital Anxiety and Depression Scale), anxiety sensitivity (Anxiety Sensitivity Index-3), personality factors (Big Five Inventory-10), and fear-…

Malemedicine.medical_specialtyPersonality InventoryPsychometricsChronic tinnitusAnxietyHospital Anxiety and Depression ScaleTinnitusCognitionSurveys and Questionnairesotorhinolaryngologic diseasesmedicineAvoidance LearningHumansPsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesPrincipal Component AnalysisDepressionChronic painCognitionFearMiddle Agedmedicine.diseaseClinical PsychologyChronic DiseaseAnxiety sensitivityAnxietyRegression AnalysisFemalemedicine.symptomPsychologyTinnitusClinical psychologyCognitive behaviour therapy
researchProduct

Psychometric Analysis of the Selective Reminding Procedure in a Sample from the General Elderly Population

2000

The selective reminding procedure (SRP) has been proposed for the assessment of distinct aspects of episodic memory, i.e. storage to and retrieval from short-term and long-term memory, item learning and list learning, and as dementia screening tool. In the present study SRP results were analysed in 256 probands from the general elderly population. SRP scores were highly intercorrelated, and principal component analysis yielded only one single factor. The SRP scores were moderately and not differentially correlated with immediate and delayed free recall and recognition and with verbal fluency. All SRP scores discriminated nondemented probands with episodic long-term memory impairment from th…

Malemedicine.medical_specialtyPsychometricsCognitive NeuroscienceAudiologyenvironment and public healthDevelopmental psychologyMemorymedicineHumansMemory impairmentSemantic memoryVerbal fluency testEpisodic memoryAgedAged 80 and overPsychiatric Status Rating ScalesMemory DisordersWorking memoryMemoriaReproducibility of ResultsCognitionPsychiatry and Mental healthFree recallDementiaFemaleGeriatrics and GerontologyFactor Analysis StatisticalPsychologyDementia and Geriatric Cognitive Disorders
researchProduct

Distigmine bromide induced acute psychotic disorder in a patient with multiple sclerosis.

2003

AbstractA female patient with multiple sclerosis (MS) suffered from an acute psychotic disorder after taking distigmine bromide for detrusor dysfunction. She showed a dramatic relief of her symptoms after the medication, distigmine bromide, was stopped. Distigmine is not supposed to penetrate the blood-brain barrier (BBB). However, in MS patients a leakage of the BBB could be hypothesized.

Malemedicine.medical_specialtyPsychosisMultiple Sclerosismedicine.medical_treatmentPyridinium CompoundsSuicide AttemptedBlood–brain barrierPsychoses Substance-InducedCentral nervous system diseasechemistry.chemical_compoundBromidemedicineHumansDistigminePsychiatric Status Rating ScalesChemotherapybusiness.industryMultiple sclerosisUrinary Retentionmedicine.diseasePathophysiologySurgeryPsychiatry and Mental healthmedicine.anatomical_structurechemistryParasympathomimeticsAnesthesiaFemalebusinessmedicine.drugEuropean psychiatry : the journal of the Association of European Psychiatrists
researchProduct

Androgen receptor assays in specimens of prostatic tissue obtained by transurethral resection and transvesical adenomectomy

1991

The main goal of this study was to ascertain whether routine transurethral resection (TUR) of prostate may provide useful material for the evaluation of androgen receptor (AR) status. At the same time, either intracellular distribution of binding affinity and capacity of receptor molecules were particularly taken into account. Based on our previous findings in breast and endometrial cancer, we suggest that a "functional" receptor status may correspond to the presence of type I (high affinity, low capacity) AR in both soluble and nuclear fractions. However, the precise significance of type II (lower affinity, higher capacity) binding sites remains to be clarified. Ten samples of large prosta…

Malemedicine.medical_specialtyReceptor StatusUrologymedicine.medical_treatmentProstatic HyperplasiaUrologySpecimen HandlingRadioligand AssayProstateInternal medicineElectrocoagulationmedicineRadioligandHumansMiboleroneReceptorProstatectomyChemistryEndometrial cancerProstatemedicine.diseaseIn vitroAndrogen receptorEndocrinologymedicine.anatomical_structureReceptors AndrogenUrological Research
researchProduct

Smoking differently modifies suicide risk of affective disorders, substance use disorders, and social factors

2008

Abstract Background Although an association between smoking and suicide has repeatedly been shown, information about a modifying influence of smoking on other risk factors for suicide is lacking. Methods Axis I and Axis II disorders, sociodemographic factors, and tobacco use were assessed by a semi-structured interview including the Structured Clinical Interview for DSM-IV Axis I (SCID-I) and Personality Disorders (SCID-II) in 163 suicides (mean age 49.6 +/− 19.3 years; 64.4% men;) by psychological autopsy method and by personal interview in 396 living population-based control persons (mean age 51.6 +/− 17.0 years; 55.8% men). Results Smoking status (current smokers, lifetime non-smokers, a…

Malemedicine.medical_specialtySubstance-Related Disordersmedicine.medical_treatmentPoison controlComorbidityPersonality DisordersSuicide preventionRisk FactorsGermanyPrevalencemedicineHumansRisk factorPsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesDepressive Disorder MajorMood DisordersResearchSmokingMiddle Agedmedicine.diseaseControl GroupsPersonality disordersDiagnostic and Statistical Manual of Mental DisordersSubstance abuseSuicidePsychiatry and Mental healthClinical PsychologySocioeconomic FactorsMood disordersCase-Control StudiesSmoking cessationFemaleSmoking CessationPsychologyClinical psychologyJournal of Affective Disorders
researchProduct

FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment

2006

Specific patterns of cortical glucose metabolism disturbances and increased CSF phospho-tau (p-tau(181)) concentrations could be demonstrated to predict cognitive decline and shift to dementia in amnestic mild cognitive impairment (MCI). But comparisons of both diagnostic tools have not been undertaken so far. The aim of the study was to compare (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) findings and CSF phospho-tau (p-tau(181)) measurements in the prediction of cognitive deterioration and conversion to dementia in MCI. During follow-up (mean 19 months) eight of 16 patients (50%) showed progressive cognitive decline, and four patients shifted to dementia. Patholog…

Malemedicine.medical_specialtyTau proteinNeuroscience (miscellaneous)tau ProteinsKaplan-Meier EstimateSeverity of Illness IndexStereotaxic TechniquesCentral nervous system diseaseImaging Three-DimensionalDegenerative diseaseFluorodeoxyglucose F18Internal medicinemental disordersSeverity of illnessImage Processing Computer-AssistedmedicineHumansDementiaRadiology Nuclear Medicine and imagingLongitudinal StudiesCognitive declineAgedPsychiatric Status Rating ScalesbiologyCognitive disorderPrognosismedicine.diseasePsychiatry and Mental healthPositron-Emission TomographyStereotaxic techniquebiology.proteinCardiologyDementiaFemaleCognition DisordersMental Status SchedulePsychologyNeuroscienceBiomarkersFollow-Up StudiesPsychiatry Research: Neuroimaging
researchProduct

Sex-specific differences drive temporal trends and outcomes of patients hospitalized for heart failure in Germany

2020

Despite remarkable improvements in treatment of cardiovascular disease, heart failure (HF) is still characterized by high mortality rate. Sex-specific differences in HF have been described, but underlying reasons are widely unexplored.The nationwide German inpatient sample (2005-2016) was used for this sex-specific analyses. Temporal trends on hospitalizations, mortality, and treatments were analysed and independent predictors of adverse outcomes identified.The analysis comprises 4,538,977 hospitalizations due to HF (52.0%women) in Germany (2005-2016). Although women were older (median 82(IQR75-87) vs.76(69-82),P  0.001), coronary artery disease (CAD, 50.3% vs. 30.7%,P  0.001) was more prev…

Malemedicine.medical_specialtyTime FactorsDatabases FactualAdverse outcomesMEDLINEDisease030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciencesSex Factors0302 clinical medicineGermanyInternal medicineCase fatality ratePrevalencemedicineHumansHospital Mortality030212 general & internal medicineHealthcare DisparitiesAgedAged 80 and overHeart Failurebusiness.industryIncidenceMortality rateIncidence (epidemiology)Health Status Disparitiesmedicine.diseaseSex specificHospitalizationOutcome and Process Assessment Health CareTreatment OutcomeHeart Disease Risk FactorsHeart failureFemaleCardiology and Cardiovascular MedicinebusinessProgress in Cardiovascular Diseases
researchProduct

Effects of clinical and laboratory variables at admission and of in-hospital treatment with cardiovascular drugs on short term prognosis of ischemic …

2011

Abstract Introduction No information exists, to our knowledge, about the possible role of cardiovascular drug administration in the acute phase of ischemic stroke and possible effects on stroke outcome. The aim of our study was to evaluate the relationship between in-hospital treatment with cardiovascular drugs in patients with acute ischemic stroke and some outcome indicators. Methods and Results 1096 subjects enrolled in the GIFA study, who had a main discharge diagnosis of ischemic stroke represent the final sample. Drugs considered for the analysis were the following: ACE-inhibitors (ACEI), angiotensin II receptor blockers (ARBs), statins, calcium-channel-blockers (CCBs), antiplatelet (…

Malemedicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismHypercholesterolemiaMedicine (miscellaneous)Angiotensin II Receptor BlockersCharlson indexAngiotensin-Converting Enzyme InhibitorsComorbidityBrain IschemiaInternal medicineActivities of Daily LivingmedicineHumansIn patientcardiovascular diseasesStrokeGeriatric AssessmentAgedRetrospective StudiesNutrition and Dieteticsbusiness.industryCardiovascular AgentsHeparinmedicine.diseaseCalcium Channel BlockersPrognosisStrokeHospital treatmentItalyIschemic strokeHypertensionPhysical therapyFunctional statusFemaleCardiology and Cardiovascular MedicinebusinessCognition DisordersPlatelet Aggregation Inhibitorsmedicine.drugNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

Pancreatic enzyme therapy in childhood celiac disease. A double-blind prospective randomized study.

1995

The validity of pancreatic enzyme substitution therapy in the two months following diagnosis of celiac disease was investigated. Twenty patients (8 males, 12 females), mean age 14.2 months (group A) received an enzyme substitution preparation. The control group (group B) included 20 patients (9 males, 11 females), mean age 14.5 months, treated with placebo. Before starting treatment, we performed a stratification for age, weight-for-age at diagnosis, and degree of pancreatic insufficiency. The therapies were then administered randomly in double-blind fashion. On diagnosis and 30 and 60 days after commencement of a gluten-free diet with identical calorie intake in both groups, a series of an…

Malemedicine.medical_specialtyTime FactorsGlutensPhysiologyNutritional StatusPlaceboWeight GainGastroenterologyGroup AGroup BCoeliac diseaselaw.inventionRandomized controlled trialDouble-Blind MethodGastrointestinal AgentslawInternal medicinemedicineHumansProspective StudiesProspective cohort studybusiness.industryGastroenterologyInfantmedicine.diseaseCeliac DiseasePancreatic Function Testsmedicine.anatomical_structureChild PreschoolPancreatinFemalemedicine.symptomPancreasbusinessWeight gainDigestive diseases and sciences
researchProduct